FDA Adverse Event Injury Summary report: N

KINETRA

MDR report key: 2480639 · Received March 6, 2012

Report

Report Number
3007566237-2012-00482
Event Type
Injury
Date Received
March 6, 2012
Date of Event
August 19, 2011
Report Date
February 21, 2012
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4)

Description of Event or Problem · 1

LITERATURE: MOTOR IMPROVEMENT WITH BILATERAL SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A PATIENT WITH LEVODOPA-RESPONSIVE SECONDARY PARKINSONISM. VIKAS KOTAGALA,*, PARAG G. PATILB, KELVIN L. CHOUC. PARKINSONISM AND RELATED DISORDERS 18 (2012) 79-81. DOI:10. 1016/J.PARKRELDIS.2011.08.014. ABSTRACT: AT MANY CENTERS, SUBTHALAMIC NUCLEUS (STN) DEEP BRAIN STIMULATION (DBS) IS NOT CONSIDERED FOR PATIENTS WITH SECONDARY FORMS OF PARKINSONISM, DUE TO HIGHER EXPECTED RATES OF TREATMENT FAILURE. WE PRESENT THE CASE OF A WOMAN WITH SECONDARY PARKINSONISM THAT DEVELOPED FOLLOWING A MEASLES, MUMPS, AND RUBELLA (MMR) VACCINATION, WHO EXPERIENCED SUSTAINED IMPROVEMENT IN MOTOR FUNCTION FOLLOWING STN DBS. DESPITE THE DIAGNOSIS OF A SECONDARY PARKINSONISM, THIS PATIENT RESPONDED WELL TO DOPAMINERGIC THERAPY, A GOOD PREDICTOR OF DBS OUTCOME IN PATIENTS WITH IDIOPATHIC PARKINSON'S DISEASE. THIS CASE SUGGESTS THAT DBS MAY BE CONSIDERED IN THE SETTING OF SECONDARY PARKINSONISM IF SUCH PATIENTS HAVE LEVODOPA RESPONSIVE SYMPTOMS. REPORTED EVENT: THE PATIENT UNDERWENT BILATERAL STN DBS ELECTRODE PLACEMENT FOLLOWED A MONTH LATER BY IMPLANTATION OF A KINETRA STIMULATOR (B)(4). POSTOPERATIVELY, SHE HAD A WOUND INFECTION REQUIRING IV ANTIBIOTICS BUT HAD NO TREMOR OR WEARING-OFF SYMPTOMS ONCE STIMULATION PARAMETERS WERE OPTIMIZED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 KINETRA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC NEUROMODULATION NEU_INS_STIMULATOR

Patients

Seq Age Sex Outcome Treatment
1 00062 YR Required Intervention